Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 16, 2015, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $101.50 to $30,000,001.88.

Highlighted Stocks Traded by Insiders:

Home Properties (HME) - FREE Research Report

Hague Donald R., who is Senior Vice President at Home Properties, sold 1,456 shares at $66.11 on March 16, 2015. Following this transaction, the Senior Vice President owned 14,945 shares meaning that the stake was reduced by 8.88% with the 1,456-share transaction.

The shares most recently traded at $68.30, up $2.19, or 3.2% since the insider transaction. Historical insider transactions for Home Properties go as follows:

  • 4-Week # shares bought: 1,580
  • 4-Week # shares sold: 245
  • 12-Week # shares bought: 1,580
  • 12-Week # shares sold: 673
  • 24-Week # shares bought: 1,580
  • 24-Week # shares sold: 973

The average volume for Home Properties has been 383,900 shares per day over the past 30 days. Home Properties has a market cap of $3.9 billion and is part of the financial sector and real estate industry. Shares are up 3.93% year-to-date as of the close of trading on Monday.

Home Properties, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It is engaged in the ownership, management, acquisition, rehabilitation and development of residential apartment communities. The stock currently has a dividend yield of 4.55%. The company has a P/E ratio of 41.8. Currently, there are 2 analysts who rate Home Properties a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HME - FREE

TheStreet Quant Ratings rates Home Properties as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, revenue growth, reasonable valuation levels, notable return on equity and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Home Properties Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Bear State Financial (BSF) - FREE Research Report

Bear State Financial Holdings, LLC, who is 10% Owner at Bear State Financial, bought 1,001 shares at $9.91 on March 16, 2015. Following this transaction, the 10% Owner owned 19.0 million shares meaning that the stake was boosted by 0.01% with the 1,001-share transaction.

The shares most recently traded at $9.37, down $0.54, or 5.76% since the insider transaction. Historical insider transactions for Bear State Financial go as follows:

  • 4-Week # shares sold: 426
  • 12-Week # shares sold: 426
  • 24-Week # shares sold: 426

The average volume for Bear State Financial has been 14,000 shares per day over the past 30 days. Bear State Financial has a market cap of $270.2 million and is part of the financial sector and banking industry. Shares are up 3.45% year-to-date as of the close of trading on Friday.

Bear State Financial, Inc. operates as the holding company for First Federal Bank, which provides various financial products and services to individuals and small to medium-sized businesses in Arkansas.

Exclusive Offer: Get the latest Stock Analysis on BSF - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Bristol-Myers Squibb Company (BMY) - FREE Research Report

Schmukler Louis S, who is Pres., Global Mfg. & Supply at Bristol-Myers Squibb Company, sold 12,000 shares at $66.96 on March 16, 2015. Following this transaction, the Pres., Global Mfg. & Supply owned 22,218 shares meaning that the stake was reduced by 35.07% with the 12,000-share transaction.

The shares most recently traded at $67.35, up $0.39, or 0.58% since the insider transaction. Historical insider transactions for Bristol-Myers Squibb Company go as follows:

  • 4-Week # shares sold: 18,011
  • 12-Week # shares sold: 77,141
  • 24-Week # shares sold: 427,141

The average volume for Bristol-Myers Squibb Company has been 6.4 million shares per day over the past 30 days. Bristol-Myers Squibb Company has a market cap of $111.1 billion and is part of the health care sector and drugs industry. Shares are up 15.25% year-to-date as of the close of trading on Monday.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The stock currently has a dividend yield of 2.21%. The company has a P/E ratio of 55.7. Currently, there are 9 analysts who rate Bristol-Myers Squibb Company a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BMY - FREE

TheStreet Quant Ratings rates Bristol-Myers Squibb Company as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and disappointing return on equity. Get the full Bristol-Myers Squibb Company Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null